Skip to main content
. 2018 Apr;6(8):151. doi: 10.21037/atm.2018.04.06

Table 1. Baseline and Phadiatop positivity in the study population.

Class§ Asthma group (n)* Non-asthma group (n)*
Phadiatop hx2 mx2 tx4 wx5 Phadiatop hx2 mx2 tx4 wx5
1 21 13 20 9 7 5 3 1 0 0
2 36 33 13 12 12 12 9 0 2 2
3 25 14 3 1 3 7 3 0 1 1
4 28 31 1 0 0 2 3 0 0 0
5 17 13 0 0 0 0 0 0 0 0
6 7 7 0 0 0 0 0 0 0 0
Total 134 111 37 22 22 26 18 1 3 3

*, the number of serum samples tested positive by Phadiatop or by previous ImmunoCAP assays (for hx2, mx2, tx4 and wx5); §, the positive responses are classified by the total Phadiatop or ImmunoCAP sIgE levels as follows: class 1, ≥0.35 and <0.70 kUA/L; class 2, ≥0.70 and <3.50 kUA/L; class 3, ≥3.50 and <17.50 kUA/L; class 4, ≥17.50 and <50.00 kUA/L; class 5, ≥50.00 and <100.00 kUA/L; class 6, ≥100.00 kUA/L. hx2, house dust mix; mx2, molds and yeasts mix; tx4, tree pollen mix; wx5, weed mix.